It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Gene-environment interactions, by means of abnormal macromolecular intestinal adsorption, is one of the possible causes of autism spectrum disorders (ASD) predominantly in patients with gastrointestinal disorders. Pre-haptoglobin-2 (zonulin), encoded by the Haptoglobin (HP) allele-2 gene, enhances the intestinal permeability by modulation of intercellular tight junctions. The two alleles of HP, HP1 and HP2, differ for 2 extra exons in HP2 that result in exon duplication undetectable by classic genome-wide association studies. To evaluate the role of HP2 in ASD pathogenesis and to set up a method to discriminate HP alleles, Italian subjects with ASD (n = 398) and healthy controls (n = 379) were genotyped by PCR analysis; subsequently, the PCR results were integrated with microarray genotypes (Illumina Human Omni 1S-8), obtained using a subset from the same subjects, and then we developed a computational method to predict HP alleles. On the contrary to our expectations, there was no association between HP2 and ASD (P > 0.05), and there was no significant allele association in subjects with ASD with or without gastrointestinal disorders (P > 0.05). With the aid of bioinformatics analysis, from a window frame of ~2 Mb containing 314 SNPs, we obtain imputation accuracy (r2) between 0.4 and 0.9 (median 0.7) and correct predictions were between 70% and 100% (median 90%). The conclusions endorse that enhanced intestinal permeability in subjects with ASD should not be imputed to HP2 but to other members of the zonulin family and/or to environmental factors.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 National Research Council, Institute of Biomedical Technologies, Segrate, Italy (GRID:grid.5326.2) (ISNI:0000 0001 1940 4177)
2 University of Brescia, Department of Molecular and Translational Medicine, Biology and Genetic Unit, Brescia, Italy (GRID:grid.7637.5) (ISNI:0000000417571846)
3 University of Brescia, Department of Molecular and Translational Medicine, Biology and Genetic Unit, Brescia, Italy (GRID:grid.7637.5) (ISNI:0000000417571846); IRCCS Istituto Centro S. Giovanni di Dio, Fatebenefratelli, Genetics Unit, Brescia, Italy (GRID:grid.7637.5)
4 IRCCS Eugenio Medea, Scientific Institute, Lecco, Italy (GRID:grid.420417.4)
5 University of Siena, Medical Genetics, Siena, Italy (GRID:grid.9024.f) (ISNI:0000 0004 1757 4641); Azienda Ospedaliera Universitaria Senese, Genetica Medica, Siena, Italy (GRID:grid.411477.0) (ISNI:0000 0004 1759 0844)
6 University of Siena, Medical Genetics, Siena, Italy (GRID:grid.9024.f) (ISNI:0000 0004 1757 4641)
7 University of Salerno, Department Chemistry and Biology, “A. Zambelli”, Fisciano, Italy (GRID:grid.11780.3f) (ISNI:0000 0004 1937 0335)
8 Massachusetts General Hospital - Harvard Medical School, Mucosal Immunology and Biology Research Center, Center for Celiac Research and Treatment, and Division of Pediatric Gastroenterology and Nutrition, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); EBRIS Foundation, European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy (GRID:grid.32224.35)